Variant report

Variant	nsv529036
Chromosome Location	chr9:115652836-115655849
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:69)
CpG islands
(count:306)
Chromatin interactive
region (count:4)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:69 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr9:115652819-115653393	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTCF	chr9:115652980-115653130	MCF-7	breast:	n/a	n/a
3	CTCF	chr9:115653110-115653151	MCF-7	breast:	n/a	n/a
4	CTCF	chr9:115653053-115653208	MCF-7	breast:	n/a	n/a
5	CTCF	chr9:115653080-115653169	Fibrobl	skin:	n/a	n/a
6	CTCF	chr9:115654693-115654806	GM12878	blood:	n/a	chr9:115654757-115654775
7	CTCF	chr9:115654686-115654806	K562	blood:	n/a	chr9:115654757-115654775
8	CTCF	chr9:115653033-115653222	MCF-7	breast:	n/a	n/a
9	CTCF	chr9:115654640-115654790	MCF-7	breast:	n/a	chr9:115654757-115654775
10	CTCF	chr9:115653140-115653290	SK-N-SH_RA	brain:	n/a	n/a
11	CTCF	chr9:115654640-115654790	HFF-Myc	foreskin:	n/a	chr9:115654757-115654775
12	CTCF	chr9:115654680-115654830	WERI-Rb-1	eye:	n/a	chr9:115654757-115654775
13	CTCF	chr9:115654667-115654809	HepG2	liver:	n/a	chr9:115654757-115654775
14	CTCF	chr9:115653128-115653141	LNCaP	prostate:	n/a	n/a
15	CTCF	chr9:115654680-115654830	GM12871	blood:	n/a	chr9:115654757-115654775
16	CTCF	chr9:115653078-115653178	MCF-7	breast:	n/a	n/a
17	CTCF	chr9:115654720-115654808	HepG2	liver:	n/a	chr9:115654757-115654775
18	CTCF	chr9:115653060-115653210	HEK293	kidney:	n/a	n/a
19	CTCF	chr9:115654740-115654890	GM12873	blood:	n/a	chr9:115654757-115654775
20	CTCF	chr9:115654780-115654930	HCM	heart:	n/a	n/a
21	CTCF	chr9:115654758-115654796	GM19240	blood:	n/a	n/a
22	CTCF	chr9:115653060-115653210	HMEC	breast:	n/a	n/a
23	CTCF	chr9:115653100-115653250	GM12866	blood:	n/a	n/a
24	CTCF	chr9:115653020-115653170	AG09319	gingival:	n/a	n/a
25	CTCF	chr9:115653100-115653250	HCM	heart:	n/a	n/a
26	CTCF	chr9:115654760-115654910	GM12872	blood:	n/a	n/a
27	CTCF	chr9:115654681-115654786	GM12891	blood:	n/a	chr9:115654757-115654775
28	CTCF	chr9:115654700-115654850	HEK293	kidney:	n/a	chr9:115654757-115654775
29	CTCF	chr9:115654740-115654890	NB4	blood:	n/a	chr9:115654757-115654775
30	CTCF	chr9:115654660-115654810	HRPEpiC	eye:	n/a	chr9:115654757-115654775
31	CTCF	chr9:115654740-115654890	HepG2	liver:	n/a	chr9:115654757-115654775
32	CTCF	chr9:115654713-115654801	K562	blood:	n/a	chr9:115654757-115654775
33	E2F6	chr9:115652343-115653595	H1-hESC	embryonic stem cell:	n/a	n/a
34	E2F6	chr9:115652270-115653367	H1-hESC	embryonic stem cell:	n/a	n/a
35	EGR1	chr9:115655691-115655839	K562	blood:	n/a	chr9:115655804-115655817 chr9:115655803-115655818
36	ESR1	chr9:115653049-115653518	ECC-1	luminal epithelium:	n/a	chr9:115653339-115653356
37	ESR1	chr9:115653122-115653540	ECC-1	luminal epithelium:	n/a	chr9:115653339-115653356
38	ESR1	chr9:115653034-115653479	ECC-1	luminal epithelium:	n/a	chr9:115653339-115653356
39	ESR1	chr9:115653082-115653600	ECC-1	luminal epithelium:	n/a	chr9:115653339-115653356
40	ESR1	chr9:115653185-115653456	ECC-1	luminal epithelium:	n/a	chr9:115653339-115653356
41	GABPA	chr9:115653107-115653408	H1-hESC	embryonic stem cell:	n/a	n/a
42	HA-E2F1	chr9:115652859-115653583	MCF-7	breast:	n/a	n/a
43	HDAC2	chr9:115652513-115653543	MCF-7	breast:	n/a	chr9:115653158-115653177
44	MAX	chr9:115652742-115653435	ECC-1	luminal epithelium:	n/a	n/a
45	MAX	chr9:115652664-115653484	ECC-1	luminal epithelium:	n/a	n/a
46	MAX	chr9:115652737-115653490	MCF-7	breast:	n/a	n/a
47	MAX	chr9:115652218-115653557	H1-hESC	embryonic stem cell:	n/a	n/a
48	MAX	chr9:115652193-115653494	H1-hESC	embryonic stem cell:	n/a	n/a
49	MXI1	chr9:115653240-115653297	H1-hESC	embryonic stem cell:	n/a	n/a
50	MYC	chr9:115653045-115653403	MCF-7	breast:	n/a	n/a

(count:306 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:115652824-115652874	NHBE	bronchial:	n/a
2	chr9:115652824-115652874	NHBE	bronchial:	n/a
3	chr9:115652824-115652874	HAEpiC	amniotic membrane:	n/a
4	chr9:115653543-115653593	MCF10A-Er-Src	breast:	n/a
5	chr9:115653543-115653593	HCM	heart:	n/a
6	chr9:115653026-115653076	SK-N-SH_RA	brain:	n/a
7	chr9:115653026-115653076	HEEpiC	esophagus:	n/a
8	chr9:115652824-115652874	HPAEpiC	pulmonary alveolar:	n/a
9	chr9:115652824-115652874	AG10803	skin:	n/a
10	chr9:115653543-115653593	HepG2	liver:	n/a
11	chr9:115653026-115653076	NHBE	bronchial:	n/a
12	chr9:115653802-115653852	HCM	heart:	n/a
13	chr9:115653802-115653852	BE2_C	brain:	n/a
14	chr9:115652824-115652874	HCPEpiC	choroid plexus:	n/a
15	chr9:115653222-115653272	GM12892	blood:	n/a
16	chr9:115653222-115653272	HUVEC	blood vessel:	n/a
17	chr9:115653543-115653593	BE2_C	brain:	n/a
18	chr9:115652824-115652874	SKMC	muscle:	n/a
19	chr9:115653543-115653593	HCT-116	colon:	n/a
20	chr9:115653543-115653593	NB4	blood:	n/a
21	chr9:115653222-115653272	NHDF-neo	bronchial:	n/a
22	chr9:115653222-115653272	A549	lung:	n/a
23	chr9:115653026-115653076	NHDF-neo	bronchial:	n/a
24	chr9:115653802-115653852	HNPCEpiC	eye:	n/a
25	chr9:115653802-115653852	GM12891	blood:	n/a
26	chr9:115653543-115653593	PrEC	prostate:	n/a
27	chr9:115652824-115652874	SAEC	small airway:	n/a
28	chr9:115653543-115653593	K562	blood:	n/a
29	chr9:115653222-115653272	Hela-S3	cervix:	n/a
30	chr9:115653026-115653076	NH-A	brain:	n/a
31	chr9:115652824-115652874	Jurkat	blood:	n/a
32	chr9:115652824-115652874	AG09319	gingival:	n/a
33	chr9:115653222-115653272	HPAEpiC	pulmonary alveolar:	n/a
34	chr9:115653222-115653272	HCPEpiC	choroid plexus:	n/a
35	chr9:115653026-115653076	HPAEpiC	pulmonary alveolar:	n/a
36	chr9:115653026-115653076	PrEC	prostate:	n/a
37	chr9:115653222-115653272	Jurkat	blood:	n/a
38	chr9:115653222-115653272	BJ	skin:	n/a
39	chr9:115653543-115653593	AG10803	skin:	n/a
40	chr9:115653026-115653076	HCM	heart:	n/a
41	chr9:115652824-115652874	HCM	heart:	n/a
42	chr9:115653802-115653852	HCF	heart:	n/a
43	chr9:115653543-115653593	A549	lung:	n/a
44	chr9:115652824-115652874	HIPEpiC	eye:	n/a
45	chr9:115653543-115653593	SKMC	muscle:	n/a
46	chr9:115652824-115652874	GM12892	blood:	n/a
47	chr9:115653543-115653593	GM12891	blood:	n/a
48	chr9:115653543-115653593	NHDF-neo	bronchial:	n/a
49	chr9:115653026-115653076	SK-N-SH	brain:	n/a
50	chr9:115653802-115653852	LNCaP	prostate:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:115647367..115649652-chr9:115652587..115654849,2	MCF-7	breast:
2	chr9:115653409..115654935-chr9:115663870..115665546,2	MCF-7	breast:
3	chr9:115653737..115657233-chr9:115662868..115665778,3	K562	blood:
4	chr9:115653499..115655772-chr9:115659487..115662405,2	MCF-7	breast:

No data

Variant related genes	Relation type
SLC46A2	TF binding region
SLC46A2	CpG island
ENSG00000271631	chromatin interactions

Extended variants
information (count: 131 )
Associated
traits (count: 53 )

Variant overlapped rSNPs/rCNVs (count:131 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs3802492	chr9:115652836-115652837	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	mRNA abundance
2	rs528171072	chr9:115652849-115652850	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs376720617	chr9:115652864-115652865	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs200301213	chr9:115652865-115652866	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs531041114	chr9:115652869-115652870	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs3802491	chr9:115652881-115652882	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs17854546	chr9:115652886-115652887	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs113536215	chr9:115652890-115652891	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs3802490	chr9:115652927-115652928	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs145291738	chr9:115652936-115652937	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs73656454	chr9:115652938-115652939	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs539106130	chr9:115652955-115652956	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs201915674	chr9:115652972-115652973	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs187784798	chr9:115652990-115652991	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs370577663	chr9:115653004-115653005	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs114523581	chr9:115653016-115653017	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs536810172	chr9:115653024-115653025	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs556747806	chr9:115653025-115653026	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs13283782	chr9:115653026-115653027	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	mRNA abundance
20	rs542561419	chr9:115653035-115653036	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs200371278	chr9:115653057-115653058	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs532340073	chr9:115653082-115653083	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs537659681	chr9:115653092-115653093	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs572541909	chr9:115653104-115653105	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs144917707	chr9:115653108-115653109	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs564803312	chr9:115653129-115653130	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs530648710	chr9:115653150-115653151	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs544430959	chr9:115653218-115653219	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs550815816	chr9:115653221-115653222	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs561509771	chr9:115653227-115653228	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs530406316	chr9:115653239-115653240	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs547349906	chr9:115653244-115653245	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs569284186	chr9:115653264-115653265	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs566848817	chr9:115653270-115653271	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs532374358	chr9:115653296-115653297	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs552557393	chr9:115653327-115653328	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs536065430	chr9:115653379-115653380	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs368580846	chr9:115653432-115653433	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs376956309	chr9:115653436-115653437	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs114688945	chr9:115653438-115653439	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs538340173	chr9:115653440-115653441	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs192568975	chr9:115653441-115653442	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs115361893	chr9:115653449-115653450	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs567165158	chr9:115653458-115653459	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs536126056	chr9:115653480-115653481	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs552879920	chr9:115653511-115653512	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs573115559	chr9:115653537-115653538	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs548354212	chr9:115653541-115653542	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs544647694	chr9:115653552-115653553	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs372276512	chr9:115653601-115653602	Bivalent/Poised TSS Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:53)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Medulloblastoma	21979893	CNVD
microdeletion syndrome	16199537	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Urothelial carcinoma	21177765	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Myelofibrosis	22110671	CNVD
lymphocytic leukemia	21291569	CNVD
Leukemia	17361228	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Glioblastoma	16823260	CNVD
Non-small cell lung cancer	21044232	CNVD
Brain cancer	20823417	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Renal cell carcinoma	19461508	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Heart disease	21282601	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	17603634	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	18632612	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Gastric cancer	17908304	CNVD
small cell lung cancer	20016488	CNVD
Cardiac fibroma	18329553	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	21364760	CNVD
Developmental delay	21147756	CNVD
Lung cancer	19147751	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Melanoma	18172304	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:196 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:115650800-115653000	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
2	chr9:115651800-115653000	Bivalent/Poised TSS	Fetal Thymus	thymus
3	chr9:115652200-115653000	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr9:115652200-115653200	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
5	chr9:115652200-115653600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
6	chr9:115652200-115653600	Bivalent/Poised TSS	Primary mononuclear cells fromperipheralblood	Blood
7	chr9:115652400-115653000	Flanking Active TSS	Right Ventricle	heart
8	chr9:115652400-115653000	Bivalent Enhancer	Stomach Mucosa	stomach
9	chr9:115652400-115653200	Bivalent/Poised TSS	Brain Cingulate Gyrus	brain
10	chr9:115652400-115653200	Flanking Active TSS	Osteobl	bone
11	chr9:115652400-115653400	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
12	chr9:115652400-115653400	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
13	chr9:115652400-115653400	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
14	chr9:115652400-115653400	Flanking Bivalent TSS/Enh	Esophagus	oesophagus
15	chr9:115652400-115653400	Bivalent Enhancer	Fetal Brain Male	brain
16	chr9:115652400-115653400	Flanking Active TSS	Lung	lung
17	chr9:115652400-115653600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
18	chr9:115652400-115653600	Bivalent Enhancer	Primary B cells from peripheral blood	blood
19	chr9:115652400-115653600	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
20	chr9:115652400-115653600	Flanking Active TSS	Adipose Nuclei	Adipose
21	chr9:115652400-115653800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
22	chr9:115652600-115653000	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
23	chr9:115652600-115653000	Flanking Bivalent TSS/Enh	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
24	chr9:115652600-115653000	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
25	chr9:115652600-115653000	Bivalent Enhancer	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
26	chr9:115652600-115653000	Flanking Active TSS	Liver	Liver
27	chr9:115652600-115653000	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
28	chr9:115652600-115653000	Flanking Bivalent TSS/Enh	Brain Dorsolateral Prefrontal Cortex	brain
29	chr9:115652600-115653000	Flanking Bivalent TSS/Enh	Brain Substantia Nigra	brain
30	chr9:115652600-115653000	Bivalent/Poised TSS	Fetal Kidney	kidney
31	chr9:115652600-115653000	Flanking Bivalent TSS/Enh	Fetal Muscle Leg	muscle
32	chr9:115652600-115653000	Flanking Bivalent TSS/Enh	Placenta	Placenta
33	chr9:115652600-115653000	Flanking Bivalent TSS/Enh	Rectal Mucosa Donor 29	rectum
34	chr9:115652600-115653000	Flanking Bivalent TSS/Enh	Rectal Mucosa Donor 31	rectum
35	chr9:115652600-115653000	Flanking Bivalent TSS/Enh	Skeletal Muscle Male	skeletal muscle
36	chr9:115652600-115653200	Flanking Active TSS	Gastric	stomach
37	chr9:115652600-115653200	Active TSS	Monocytes-CD14+_RO01746	blood
38	chr9:115652600-115653200	Bivalent/Poised TSS	NHLF	lung
39	chr9:115652600-115653400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
40	chr9:115652600-115653400	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells short term culture	blood
41	chr9:115652600-115653400	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Female	--
42	chr9:115652600-115653400	Flanking Bivalent TSS/Enh	Cortex derived primary cultured neurospheres	brain
43	chr9:115652600-115653400	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
44	chr9:115652600-115653400	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
45	chr9:115652600-115653400	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin01	Skin
46	chr9:115652600-115653400	Active TSS	Brain Anterior Caudate	brain
47	chr9:115652600-115653400	Flanking Bivalent TSS/Enh	Duodenum Mucosa	Duodenum
48	chr9:115652600-115653400	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
49	chr9:115652600-115653400	Bivalent/Poised TSS	Rectal Smooth Muscle	rectum
50	chr9:115652600-115653400	Flanking Bivalent TSS/Enh	Stomach Smooth Muscle	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links